Logo image of PAR

PAR TECHNOLOGY CORP/DEL (PAR) Stock Fundamental Analysis

NYSE:PAR - New York Stock Exchange, Inc. - US6988841036 - Common Stock - Currency: USD

55.84  +1 (+1.82%)

After market: 55.84 0 (0%)

Fundamental Rating

3

Taking everything into account, PAR scores 3 out of 10 in our fundamental rating. PAR was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. PAR may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, PAR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year PAR has reported negative net income.
PAR had a negative operating cash flow in the past year.
PAR had negative earnings in each of the past 5 years.
PAR had a negative operating cash flow in each of the past 5 years.
PAR Yearly Net Income VS EBIT VS OCF VS FCFPAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

PAR has a Return On Assets (-0.36%) which is in line with its industry peers.
With a Return On Equity value of -0.57%, PAR perfoms like the industry average, outperforming 51.61% of the companies in the same industry.
Industry RankSector Rank
ROA -0.36%
ROE -0.57%
ROIC N/A
ROA(3y)-5.72%
ROA(5y)-7.27%
ROE(3y)-13.33%
ROE(5y)-14.89%
ROIC(3y)N/A
ROIC(5y)N/A
PAR Yearly ROA, ROE, ROICPAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

With a decent Gross Margin value of 41.75%, PAR is doing good in the industry, outperforming 74.19% of the companies in the same industry.
In the last couple of years the Gross Margin of PAR has grown nicely.
The Profit Margin and Operating Margin are not available for PAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y23.88%
GM growth 5Y15.88%
PAR Yearly Profit, Operating, Gross MarginsPAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

3

2. Health

2.1 Basic Checks

PAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PAR has more shares outstanding
PAR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PAR has an improved debt to assets ratio.
PAR Yearly Shares OutstandingPAR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
PAR Yearly Total Debt VS Total AssetsPAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

PAR has an Altman-Z score of 2.52. This is not the best score and indicates that PAR is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.52, PAR is in line with its industry, outperforming 46.77% of the companies in the same industry.
A Debt/Equity ratio of 0.42 indicates that PAR is not too dependend on debt financing.
PAR has a worse Debt to Equity ratio (0.42) than 64.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 2.52
ROIC/WACCN/A
WACC8.66%
PAR Yearly LT Debt VS Equity VS FCFPAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

PAR has a Current Ratio of 1.95. This is a normal value and indicates that PAR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.95, PAR is in line with its industry, outperforming 41.13% of the companies in the same industry.
PAR has a Quick Ratio of 1.75. This is a normal value and indicates that PAR is financially healthy and should not expect problems in meeting its short term obligations.
PAR has a Quick ratio (1.75) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.75
PAR Yearly Current Assets VS Current LiabilitesPAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

PAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.26%, which is quite impressive.
The Revenue for PAR has decreased by -15.83% in the past year. This is quite bad
Measured over the past years, PAR shows a quite strong growth in Revenue. The Revenue has been growing by 13.33% on average per year.
EPS 1Y (TTM)55.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-15.83%
Revenue growth 3Y7.35%
Revenue growth 5Y13.33%
Sales Q2Q%-2.51%

3.2 Future

The Earnings Per Share is expected to grow by 77.56% on average over the next years. This is a very strong growth
Based on estimates for the next years, PAR will show a quite strong growth in Revenue. The Revenue will grow by 18.46% on average per year.
EPS Next Y126.24%
EPS Next 2Y77.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.8%
Revenue Next 2Y18.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PAR Yearly Revenue VS EstimatesPAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PAR Yearly EPS VS EstimatesPAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

PAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
PAR is valuated quite expensively with a Price/Forward Earnings ratio of 312.94.
PAR's Price/Forward Earnings is on the same level as the industry average.
PAR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.37.
Industry RankSector Rank
PE N/A
Fwd PE 312.94
PAR Price Earnings VS Forward Price EarningsPAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PAR Per share dataPAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PAR does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as PAR's earnings are expected to grow with 77.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.56%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PAR TECHNOLOGY CORP/DEL

NYSE:PAR (4/22/2025, 8:26:46 PM)

After market: 55.84 0 (0%)

55.84

+1 (+1.82%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-28 2025-02-28/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners107.79%
Inst Owner Change0.43%
Ins Owners1.91%
Ins Owner Change4.1%
Market Cap2.25B
Analysts82.86
Price Target91.04 (63.04%)
Short Float %11.14%
Short Ratio8.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)55.05%
Min EPS beat(2)10.11%
Max EPS beat(2)100%
EPS beat(4)2
Avg EPS beat(4)15.41%
Min EPS beat(4)-27.66%
Max EPS beat(4)100%
EPS beat(8)3
Avg EPS beat(8)-0.64%
EPS beat(12)5
Avg EPS beat(12)5.66%
EPS beat(16)7
Avg EPS beat(16)2.92%
Revenue beat(2)2
Avg Revenue beat(2)4.78%
Min Revenue beat(2)4.34%
Max Revenue beat(2)5.23%
Revenue beat(4)2
Avg Revenue beat(4)-7.17%
Min Revenue beat(4)-32.78%
Max Revenue beat(4)5.23%
Revenue beat(8)6
Avg Revenue beat(8)-1.35%
Revenue beat(12)10
Avg Revenue beat(12)1.59%
Revenue beat(16)13
Avg Revenue beat(16)1.88%
PT rev (1m)0%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-366.6%
EPS NY rev (1m)8.17%
EPS NY rev (3m)-41.76%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)1.68%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 312.94
P/S 6.42
P/FCF N/A
P/OCF N/A
P/B 2.58
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)0.18
Fwd EY0.32%
FCF(TTM)-0.8
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS8.7
BVpS21.68
TBVpS-6.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.36%
ROE -0.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.75%
FCFM N/A
ROA(3y)-5.72%
ROA(5y)-7.27%
ROE(3y)-13.33%
ROE(5y)-14.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y23.88%
GM growth 5Y15.88%
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.9%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.75
Altman-Z 2.52
F-Score3
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)28.88%
Cap/Depr(5y)37.84%
Cap/Sales(3y)2.92%
Cap/Sales(5y)3.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y126.24%
EPS Next 2Y77.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.83%
Revenue growth 3Y7.35%
Revenue growth 5Y13.33%
Sales Q2Q%-2.51%
Revenue Next Year20.8%
Revenue Next 2Y18.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.9%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-47.85%
OCF growth 3YN/A
OCF growth 5YN/A